Enhanced Osteogenesis of Adipose Derived Stem Cells with Noggin Suppression and Delivery of BMP-2

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fan, Jiabing ^a   Park, Hyejin ^a   Tan, Steven ^a   Lee, Min ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; CHONDROITIN SULFATE; NOGGIN; SHORT HAIRPIN RNA; ALKALINE PHOSPHATASE; CARRIER PROTEIN; COLLAGEN; NOGGIN PROTEIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL STIMULATION; CELL SURFACE; CELLULAR SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSDUCTION; IN VITRO STUDY; MINERALIZATION; MOUSE; NONHUMAN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; BONE MINERALIZATION; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; STEM CELL; TISSUE SCAFFOLD; ULTRASTRUCTURE;

ADIPOSE TISSUE; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CARRIER PROTEINS; CELLS, CULTURED; CHITOSAN; CHONDROITIN SULFATES; COLLAGEN; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE, INBRED C57BL; OSTEOGENESIS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; STEM CELLS; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881567562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072474     Document Type: Article

References (41)

1. Kilgore ML, Morrisey MA, Becker DJ, Gary LC, Curtis JR, et al. (2009) Health care expenditures associated with skeletal fractures among medicare beneficiaries, 1999-2005. J Bone Miner Res 24: 2050.
2. Langer R, Vacanti JP, (1993) Tissue engineering. Science 260: 920-926.
3. Reddi AH, (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16(3): 247-52.
4. McKay B, Sandhu HS, (2002) Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 27: S66.
5. Carlisle E, Fischgrund JS, (2005) Bone morphogenetic proteins for spinal fusion. Spine J 5: 240S.
6. Aghaloo T, Jiang X, Soo C, Zhang Z, Zhang X, et al. (2007) A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther 15(10): 1872-80.
7. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG, (2006) Increased swelling complications associated with off label usage of rhBMP-2 in the anterior cervical spine. Spine 31: 2813.
8. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, et al. (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17(9-10): 1389-99.
9. Cahill KS, Chi JH, Day A, Claus EB, (2009) Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 302: 58-66.
10. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT, (2003) The BMP antagonist noggin regulates cranial suture fusion. Nature 422(6932): 625-9.
11. Stafford DA, Brunet LJ, Khokha MK, Economides AN, Harland RM, (2011) Cooperative activity of noggin and gremlin 1 in axial skeleton development. Development 138: 1005-1014.
12. Paine-Saunders S, Viviano BL, Economides AN, Saunders S, (2002) Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277(3): 2089-96.
13. Hannallah D, Peng H, Young B, Usas A, Gearhart B, et al. (2004) Retroviral delivery of noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 86-A: 80-91.
14. Smith WC, Harland RM, (1992) Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70(5): 829-40.
15. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, (2002) Structural basis of BMP signalling inhibition by the cystine knot protein noggin. Nature 2420: 636-642.
16. Gazzerro E, Gangji V, Canalis E, (1998) Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102(12): 2106-14.
17. Gazzerro E, Du Z, Devlin RD, Rydziel S, Priest L, et al. (2003) Noggin arrests stromal cell differentiation in vitro. Bone 32(2): 111-9.
18. Heldin CH, Miyazono K, Ten Dijke P, (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
19. Devlin RD, Du Z, Pereira RC, Kimble RB, et al. (2003) Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144(5): 1972-8.
20. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, (2002) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17(1): 101-10.
21. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, et al. (2003) Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 12(6): 924-34.
22. Wan DC, Pomerantz JH, Brunet LJ, Kim JB, Chou YF, et al. (2007) Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 282(36): 26450-9.
23. Takayama K, Suzuki A, Manaka T, Taguchi S, Hashimoto Y, (2009) RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J Bone Miner Metab 27(4): 402-11.
24. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, et al. (2000) Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15(4): 663-73.
25. Luginbuehl V, Meinel L, Merkle HP, Gander B, (2004) localized delivery of growth factors for bone repair. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 58: 197-208.
26. Park H, Choi B, Nguyen J, Fan J, Shafi S, et al. (2013) Anionic Carbohydrate-containing Chitosan Scaffolds for Bone Regeneration. Carbohydrate Polymers http://dx.doi.org/10.1016/j.carbpol.2013.05.023.
27. Lee M, Li W, Siu RK, Whang J, Zhang X, et al. (2009) Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 30: 6094-101.
28. Levi B, James AW, Nelson ER, Vistnes D, Wu B, et al. (2010) Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 5(6): e11177.
29. Estes BT, Diekman BO, Gimble JM, Guilak F, (2010) Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5(7): 1294-311.
30. Fan J, Gong Y, Ren L, Varshney RR, Cai D, et al. (2010) In vitro engineered cartilage using synovium-derived mesenchymal stem cells with injectable gellan hydrogels. Acta Biomater 6(3): 1178-85.
31. Aaron WJ, Theologis AA, Brugmann SA, Xu Y, Carrel AL, et al. (2009) Estrogen/Estrogen Receptor Alpha Signaling in Mouse Posterofrontal Cranial Suture Fusion. PLoS One 4(9): e7120.
32. Zhang D, Kilian KA, (2013) The effect of mesenchymal stem cell shape on the maintenance of multipotency. Biomaterials 34(16): 3962-9.
33. Sun Y, Mauerhan DR, Kneisl JS, James NH, Zinchenko N, et al. (2012) Histological Examination of Collagen and Proteoglycan Changes in Osteoarthritic Menisci Open Rheumatol J. 6: 24-32.
34. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, et al. (2006) Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 39(1): 61-71.
35. Zhao M, Zhao Z, Koh JT, Jin T, Franceschi RT, (2005) Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 95(1): 1-16.
36. Koh JT, Zhao Z, Wang Z, Lewis IS, Krebsbach PH, et al. (2008) Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 87(9): 845-9.
37. Kuwahara K, Fang JY, Yang Z, Han B, (2011) Enzymatic crosslinking and degradation of gelatin as a switch for bone morphogenetic protein-2 activity. Tissue Eng Part A 17(23-24): 2955-64.
38. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M, (2005) Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 26: 3919-28.
39. Chou YF, Dunn JC, Wu BJ, (2005) In vitro response of MC3T3-E1 pre-osteoblasts within three-dimensional apatitecoated PLGA scaffolds. J Biomed Mater Res B Appl Biomater 75: 81.
40. James AW, Levi B, Nelson ER, Peng M, Commons GW, et al. (2011) Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo. Stem Cells Dev 20(3): 427-39.
41. Hu J, Hou Y, Park H, Lee M, (2012) Beta tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering. Journal of Biomedical Materials Research A 100(7): 1680-6.